Showing results (51-60 of 124) with videos related to
Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignanciesThomas C Shea, Rebecca Bruner, Joseph M Wiley, et al.The Journal of Experimental Medicine|December 31, 2020
STING agonist promotes CAR T cell trafficking and persistence in breast cancerNuo Xu, Douglas C Palmer, Alexander C Robeson, et al.Blood|January 14, 2014
Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHDKaifeng Lisa Lin, LeShara M Fulton, Matthew Berginski, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host diseaseBruce R Blazar, Robert B Levy, Tak W Mak, et al.Plos One|March 8, 2018
Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumorsDenis R Beckford Vera, Christof C Smith, Lisa M Bixby, et al.Cancer Research|December 17, 2010
The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cellsHendrik W van Deventer, Joseph E Burgents, Qing Ping Wu, et al.Blood Advances|September 20, 2018
Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHDOleg V Kolupaev, Trisha A Dant, Hemamalini Bommiasamy, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomibKai Sun, Lisbeth A Welniak, Angela Panoskaltsis-Mortari, et al.Nature Communications|July 17, 2024
Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantationSonia J Laurie, Joseph P Foster, Danny W Bruce, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 8, 2014
Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilizationEric Chow, Kamakshi V Rao, William A Wood, et al.Pageof 13